Filing Details
- Accession Number:
- 0001209191-22-019202
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-16 16:04:49
- Reporting Period:
- 2022-03-15
- Accepted Time:
- 2022-03-16 16:04:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1808158 | Repare Therapeutics Inc. | RPTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815366 | Michael Zinda | C/O Repare Therapeutics Inc. 7210 Frederick-Banting, Suite 100 St-Laurent A8 H4S 2A1 | Evp, Chief Science Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2022-03-15 | 533 | $11.30 | 46,041 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Billionaire Hedge Funds
